COVID 19 Very High Risk Patients - the "shielded patient list"

NHS Digital has published the shielded patients list (SPL), which is enabling partner organisations across government to support and protect those who need shielding at this time.

The Government has written to these people. In due course NHS Digital will release algorithms to GP Surgeries to find "missing" patients who have not yet received a letter. Once we receive the information we will be in a position to send letters. 


What if I haven't had a letter but I think I should be in the very high risk group?

Do you have a medical condition that makes you extremely vulnerable to coronavirus?

You’re extremely vulnerable if you:
  • have had a solid organ transplant
  • have any cancer and are getting chemotherapy
  • have lung cancer and are getting radical radiotherapy
  • have cancer of the blood or bone marrow, at any stage of treatment - for example, leukaemia, lymphoma or myeloma
  • have any cancer for which you’re getting immunotherapy or other continuing antibody treatments
  • have any cancer for which you’re getting a targeted treatment which can affect the immune system - for example, protein kinase inhibitors or PARP inhibitors
  • have had bone marrow or stem cell transplants in the last 6 months, or are still taking immunosuppression drugs
  • have a severe respiratory condition - including cystic fibrosis, severe asthma or severe COPD (Chronic Obstructive Pulmonary Disease)
  • have a rare disease or inborn error of metabolism that significantly increases your risk of infection - for example SCID or homozygous sickle cell
  • are getting an immunosuppression therapy that’s sufficient to significantly increase your risk of infection
  • are pregnant, and have a significant congenital or acquired heart disease

If you feel you are at high risk you should continue to follow advice for shielded patients on

You should also register yourself for support on the website if you need extra help and support.

Local support and advice is available here